The study, which followed pregnant individuals seeking medication abortion via telehealth from April 2021 to January 2022, involved three virtual clinics operating across 20 states and Washington, DC. The patients were screened using a standardized no-test protocol, primarily relying on their medical history for an assessment of medical eligibility.

Key findings

Findings from the study revealed that among the 6,034 abortions analyzed, an overwhelming 97.7% were complete without subsequent intervention or ongoing pregnancy after the initial treatment. Moreover, an impressive 99.8% of abortions did not lead to serious adverse events, indicating the safety of the telehealth medication abortion process.

Notably, the study highlighted the importance of telehealth abortion services, especially in states where access to abortion remains legally restricted. With the advent of telehealth technology and the removal of in-person dispensing requirements by the US Food and Drug Administration (FDA), clinicians could offer remote consultations, reducing barriers such as travel, cost, and stigma-related issues.

Context and conclusions

This study comes at a crucial time, as telehealth abortion services have become essential in states where abortion remains legal amid increasing demand. The U.S. Food and Drug Administration’s decision in 2021 to remove the in-person dispensing requirement for mifepristone paved the way for a ‘no-test’ telehealth model of medication abortion care.

Telehealth abortion has proven instrumental in overcoming travel, cost, and stigma-related barriers. This became especially vital after the Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision in June 2022 allowed states to impose abortion bans, leading to increased demand in states where abortion remained legal.

Despite the proven effectiveness and safety demonstrated by the study, access to mifepristone has been under threat due to a federal court ruling reversing FDA regulatory approvals. The study highlights the importance of preserving telehealth options for medication abortion and ensuring continued access to safe and effective reproductive healthcare.

The CHAT study provides compelling evidence supporting the effectiveness and safety of telehealth medication abortion in the United States. As debates surrounding reproductive rights continue to unfold, the findings underscore the importance of preserving and expanding access to telehealth services to ensure reproductive autonomy and healthcare equity for all individuals across the country.

The U.S. telehealth market size is expected to reach USD 150.1 billion by 2030. It is expected to grow at a CAGR of 22.9% from 2023 to 2030

Several key factors are contributing to the growth of the telehealth industry in the U.S. These include the increasing adoption of digital health services, a favorable consumer base, and significant investment.

Furthermore, the growing demand for remote patient monitoring and advancements in digital communication technology that enhances healthcare services are anticipated to fuel market growth in the coming years. The shortage of physicians and clinicians in the U.S. is also expected to be a driving force behind the telehealth industry’s expansion.

For instance, a report released by the Association of American Medical Colleges in June 2021 projects a potential deficit of 37,800 to 124,000 physicians by 2034, encompassing both specialty and primary care. Furthermore, the market growth has been propelled by the increased utilization of digital healthcare platforms for remote patient visits, driven by the implementation of social distancing measures during the COVID-19 pandemic in the U.S.

This shift has significantly contributed to the expansion of the market. For example, the Centers for Disease Control and Prevention (CDC) reported a substantial 154% increase in telehealth visits in the U.S. during March 2020 compared to the previous year, specifically in March 2019.

These remote digital healthcare services have proven beneficial by reducing disease exposure risks for both patients and healthcare staff. In addition, the growing accessibility of the Internet among the U.S. population and the rising adoption of devices, such as computers, tablets, and smartphones, create potential opportunities for industry growth.

Telehealth offers potential cost savings for both patients and healthcare systems. By reducing the need for in-person visits and associated expenses, such as travel costs and facility fees, telehealth can lower overall healthcare expenditures. For instance, according to a January 2022 report by Cigna, virtual care was associated with an approximate cost reduction of $100 per visit in healthcare expenses.

Similarly, a recent publication in JAMA Network Open revealed that telehealth services played a significant role in reducing time and travel expenses for non-elderly individuals with cancer. The study reported cost savings ranging from USD 147.4 to USD 186.1 as a result of utilizing telehealth.

Moreover, telehealth can increase efficiency by reducing wait times, optimizing appointment scheduling, and streamlining administrative processes. Furthermore there is an increasing demand for remote patient monitoring services in the U.S., which enable real-time interactions between patients and physicians. These services have become more intelligent and cost-effective, leading to improved clinical outcomes.

As a result, telehealth providers are inclined to invest more in this market. To keep pace with this healthcare revolution, healthcare organizations in the U.S. are actively transforming their infrastructure. They are rapidly upgrading themselves with six crucial components: IT infrastructures, hardware, software, Internet of Things (IoT) capabilities, scalable design, data management, and patient security.

U.S. Telehealth Market Report Highlights

• The market growth can be attributed to the favorable consumer base, well-equipped digital health infrastructure, and increasing awareness regarding telehealth
• On the basis of product type, the services segment dominated the market in 2022 owing to the growing preference for telehealth applications in chronic disease management and real-time patient monitoring
• Based on delivery mode, the web-based segment led the market in 2022 owing to the increasing use of the web-based platform for telehealth and the availability of a large number of web-based telehealth solutions
• The providers end-use segment dominated the market in 2022 owing to the increasing number of providers in the U.S. and the rising adoption of telehealth platforms by providers to reduce the burden on healthcare facilities

Company Profiles

• Koninklijke Philips N.V
• GE Healthcare
• Cerner
• Siemens Healthineers
• Medtronic
• Teladoc Health Inc.
• American Well
• MD Live
• Doctor in Demand
• U.S. Med

Key Topics Covered:

Chapter 1. Methodology and Scope

1.1. Information Procurement

1.1.1. Purchased database:

1.1.1.1. The internal database

1.1.2. Market Formulation & Validation

1.2. Research Methodology

1.3. Research Scope and Assumptions

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

2.4. U.S. Telehealth Market Snapshot

Chapter 3. U.S. Telehealth Market Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.2.3. Industry Challenge

3.3. U.S. Telehealth Market Analysis Tools

3.3.1. Industry Analysis – Porter’s

3.3.2. PESTEL Analysis

3.4. Impact of COVID 19 on U.S. Telehealth Market

Chapter 4. U.S. Telehealth Market: Product Type Estimates & Trend Analysis

4.1. Segment Dashboard

4.2. U.S. Telehealth Market: Product Type Movement Analysis, USD Million, 2022 & 2030

4.2.1. Hardware

4.2.1.1. Hardware Market Estimates And Forecasts, 2018 – 2030 (USD Million)

4.2.1.1.1. Monitor

4.2.1.1.2. Medical Peripheral Devices

4.2.1.1.2.1. Medical Peripheral Devices Market Estimates And Forecasts, 2018 – 2030 (USD Million)

4.2.1.1.2.2. Blood Pressure Meters

4.2.1.1.2.3. Blood Glucose Meters

4.2.1.1.2.4. Weighing Scales

4.2.1.1.2.5. Pulse Oximeter

4.2.1.1.2.6. Peak Flow Meters

4.2.1.1.2.7. ECG Monitors

4.2.2. Software

4.2.2.1. Software Market Estimates And Forecasts, 2018 – 2030 (USD Million)

4.2.2.1.1. Standalone Software

4.2.2.1.2. Integrated Software

4.2.3. Services

4.2.3.1. Services Market Estimates And Forecasts, 2018 – 2030 (USD Million)

4.2.3.1.1. Remote Patient Monitoring

4.2.3.1.2. Real-time Interactions

4.2.3.1.3. Store and Forward

Chapter 5. U.S. Telehealth Market: Delivery Mode Estimates & Trend Analysis

5.1. Segment Dashboard

5.2. U.S. Telehealth Market: Delivery Mode Movement Analysis, USD Million, 2022 & 2030

5.2.1. Web-based

5.2.2. Cloud-based

5.2.3. On-premises

Chapter 6. U.S. Telehealth Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard

6.2. U.S. Telehealth Market: End Use Movement Analysis, USD Million, 2022 & 2030

6.2.1. Providers

6.2.2. Payers

6.2.3. Patients

Chapter 7. Competitive Landscape

7.1. Company Categorization

7.2. Key Company Market Position Analysis

7.3. Key Company Market Share Analysis

7.4. Recent Development and Impact Analysis, by key Market Participants

For more information about this report visit https://www.researchandmarkets.com/r/n2k1vp

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

DUBLIN–(BUSINESS WIRE)–The “Digital Health and Wellness Market – Global Outlook & Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.

The digital health and wellness market by revenue is expected to grow to $1,103.22 billion by 2028 from $335 billion in 2022, growing at a CAGR of 21.97%.

Digital health and wellness refer to being physically, socially, and emotionally healthy in a technology-focused world. The increasing adoption of digital technology across the world is one factor supporting the market’s growth. Digital wellness is of the utmost significance for creating balance and healthy decisions with devices and comprises technology people use for their well-being.

Factors such as growth in the adoption of smartphones, developments in coverage networks, and the increasing prevalence of health conditions impacting physical and mental wellness are driving the North American digital health & wellness market.

Further, increasing R&D funding activities for introducing safer products with differentiated functionalities will contribute to the growth of the U.S. digital health and wellness market in the coming years. The US’s leading drivers for health and well-being programs are managing physical and mental diseases or disorders such as schizophrenia, alcohol use disorder, bipolar disorder, bipolar disorder, depression, anxiety, and others.

Key Winning Imperatives in the Global Digital Health And Wellness Market

The growing usage of highly advanced technological platforms in hospitals is accelerating the adoption of healthcare robotics by making healthcare robots more sophisticated, efficient, precise, and affordable.

Digital health and wellness have made a seismic shift by bringing a new era of customized education and solutions that tend to each individualized well-being through AI. The outstanding use of wearable monitoring devices is giving rise to new dimensions in medicine, healthcare, and fitness applications, putting them into a more significant category of wireless networks known as Wireless Body Area Networks (WBANs).

Increasing Adoption of Telehealth

Telehealth has always been a primary pillar of technology-enabled care delivery which helps hospitals, health systems, and group practices deliver quality care at a distance and often also gain efficiencies, improve patient satisfaction of providers and save costs.

In addition, the COVID-19 pandemic severely challenged the health system’s capacity, thereby increasing telehealth opportunities. Virtual care and remote monitoring have never been utilized as they are today due to the COVID-19 pandemic. As federal policies remove many of the regulatory and reimbursement barriers that have hindered the more widespread adoption of telehealth, healthcare providers nationwide are using new technologies to deliver care amid social-distancing efforts to prevent coronavirus spread.

Companies such as InTouch Health, iRobot, and Vecna Technologies have developed robots that serve as the physician’s stand-in in remote clinics, community health centers, cruise ships, schools, sporting events, and even smaller hospitals. For instance, iRobot, a leader in delivering robotic solutions, made the first autonomous remote navigation robot Remote Presence Virtual Independent Telemedicine Assistant (RP-VITA).

Data Analytics Increasingly Driving Wellness

Data-driven decision-making is becoming the need of the hour, and physical and mental wellness is being reimagined. As the industry has evolved beyond measuring healthcare costs to becoming more focused on healthy lifestyles, data analytics and technology are playing a bigger role. Several investments in technologies and expanding their capabilities to measure their initiatives using big data.

Big data can provide health professionals insights into patterns that are usually difficult to detect. By enabling preventative care, early diagnosis, and personalized and consumer-centric approaches, it intends to facilitate better clinical outcomes.

Data from several sources, such as customer data from pharmacies, patient history, hospitals, cellphones, and internet searches, provide a massive pool of data, which can be used for clinical purposes to provide better opportunities for the digital health and wellness market growth.

Increasing Smartphone Penetration & mhealth Application

Psycho-graphical and demographical indicators of the population have changed drastically over the past few years. Factors such as the increased adoption of smartphones and tablets in developing countries have led to the increasing engagement of the population in health and wellness programs. Android and iOS are witnessing increasing adoption across various countries, especially in Africa.

Moreover, a large population base in various APAC countries, such as China and India, provides significant growth opportunities to the digital health and wellness market. Continuous innovation & development is leading to the launch of much more affordable smartphone options. Various smartphone vendors in the Chinese market are developing lower-cost products.

Also, the overall price of smartphones is much lower than PC and consoles, which results in higher adoption of smartphones for health and wellness programs, thereby driving the digital health & wellness market. Moreover, the rising disposable income enables the population to purchase smartphones over traditional mobile devices, leading to an increasing number of health and wellness program operators, thereby driving the market.

Data Security & Privacy Risks

Security and privacy risks are one of the major challenges for the digital health and wellness market because the nature of data and the way providers use it is vulnerable to cybersecurity attacks and data theft.

Telehealth platforms, including wearable and connected medical devices, smartphones, tablets, and remote patient monitoring systems like other computer systems, are exposed to potential hacks and security breaches, which can adversely impact the safety and effectiveness of the overall outcome of telehealth services.

COMPETITIVE LANDSCAPE

The global digital health and wellness market is highly fragmented, and the degree of fragmentation is expected to accelerate during the forecast period.

There is a significant number of global and domestic vendors across the geographies. Headspace, FranklinCovey, Vivify Health, Teladoc Health, Apple, and Samsung are the key vendors in the global digital health and wellness market. The industry has witnessed the entry of many external players, such as in-house services by large businesses and other entities in the health and fitness space that offer membership discounts to drive their share in the industry.

Mergers and acquisitions are common within the industry as players look to expand and become more comprehensive in their offerings.

Key Attributes:

Premium Insights

Technological Developments

• Wearable Technology: Monitoring Devices
• Increasing Demand for Wireless Patient Monitoring at Home
• Rise of Virtual Clinical Trials

Market Opportunities & Trends

• Increasing Adoption of Telehealth
• Growing Reign of Artificial Intelligence (Ai)
• Data Analytics Increasingly Driving Wellness

Market Growth Enablers

• Increasing Smartphone Penetration & Mhealth Application
• Incorporation of Technology for Rising Self-Care
• Rising Development in Wearable Devices

Market Restraints

• Data Security & Privacy Risks
• Lack of Standard Interoperability
• Perceived High Cost of Digital Mental Wellness Programs

Key Vendors

• Headspace
• FranklinCovey
• Vivify Health
• Teladoc Health
• Apple
• Samsung

Other Prominent Vendors

• Altopax
• Amelia Virtual Care
• BigHealth
• Calm
• CogniFit
• CuraLinc Healthcare
• Epitel
• Fitbit
• Ginger
• Global Kinetics
• HealthUnlocked
• Healthy Hero
• Koa Health
• Misu
• MyndYou
• OxfordVR
• Psycurio
• Rani Therapeutics
• Talkspace
• Twill

For more information about this report visit https://www.researchandmarkets.com/r/upau7o

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Iris Telehealth (“Iris”), a leading provider of telepsychiatry services for health systems and community health centers across the U.S., today announced that it has raised $40 million in Series B funding, led by Concord Health Partners. With this funding, Iris will accelerate its plans to improve outcomes for patients with serious mental illness by further assisting their partner healthcare organizations in helping care for and triage patients across the continuum, matching the right next level of care with each patient.

Founded in 2013, Iris is dedicated to delivering quality, sustainable behavioral health care so organizations can better support the patients who need it most. Serving almost 200 hospitals and community health centers, Iris has grown exponentially over the last 18 months, as healthcare organizations seek to provide timely, quality care to their patients. Iris’s combination of high-quality providers, best-in-class support, expertise to optimize care models, and technology has enabled healthcare providers to reimagine how behavioral health services are provided across the continuum of care.

Concord Health Partners (“Concord”) invests in expansion stage healthcare companies with innovative technologies and services that lower costs, improve quality, and expand access to care. Concord has a strategic partnership with the American Hospital Association (AHA) and a broad base of strategic limited partners to support portfolio companies and accelerate growth.

Iris has an impressive track record of partnering with health systems and other providers to enhance behavioral health services by facilitating access to the appropriate level of care,” said James Olsen, Founder and Managing Partner of Concord Health Partners. “We are excited to support Iris, expand its reach and further enhance its technology capabilities.

Columbia Pacific Advisors was an initial Iris investor and is now expanding its commitment to further support the Company as it expands access to much-needed behavioral health care services.

“We have seen Iris grow for many years and believe it is just getting started,” said Stan Baty, Co-Founder and Managing Partner of Columbia Pacific Advisors. 2We look forward to helping the Company scale to support more healthcare organizations and patients in need of quality behavioral health care.2

For the past nine years, Iris’s goal has been to provide high-quality virtual behavioral health services to help healthcare organizations increase access to life-saving care and improve patient outcomes,” said Andy Flanagan, CEO of Iris Telehealth. “This funding will help us quickly scale our services to support more healthcare organizations. We plan to leverage this funding to make a positive, long-term impact on mental health care in communities across the country.

With behavioral health patients accounting for 56% of total health costs and 77% of U.S. counties facing a psychiatrist shortage, providing timely, quality care to patients with serious mental illness has never been more critical – or challenging. Through this capital, Iris plans to help address this challenge by investing in four main areas to accelerate the expansion of its behavioral health services:

• Expanding the clinical operations team to meet growing customer demand and ensure long-term customer health.
• Scaling the go-to-market strategy to deliver quality, sustainable behavioral health care to more enterprise health systems and community health centers.
• Enhancing the product and technology capabilities to help health systems manage patients across the continuum, ensuring the right patient is receiving the right care at the right time.
• Augmenting the team of clinical and corporate employees to meet the increasing needs of patients and partners while maintaining a culture that is supportive, connected, and rooted in the shared mission of helping organizations meet their goals through exceptional care.

This funding is an extension to a round announced back in May that saw the firm take home €50 million. Including this extension, Doktor.se has garnered approximately €160.5 million in funding.

Martin Lindman, CEO & co-founder of Doktor.se, says: We are excited to welcome Tencent Holdings in our mission to provide the technology which enables safe and accessible healthcare for everyone, making the experience frictionless and efficient. Tencent shares our belief that we can give patients faster, better care in our unique combination of physical and digital healthcare. We look forward to working with them as we expand internationally.

The startup employs nurses, specialist nurses, general practitioners, specialist doctors, psychologists, counsellors and physiotherapists at its digital and physical healthcare centres.

Currently, Doktor.se’s telemedicine platform is used in countries across Europe through veterinary care chain AniCura, in Belgium through a partnership with telecommunications group Proximus and in Brazil with the digital healthcare provider ViBE.

The funds will help Doktor.se to further expand its digi-physical services by acquiring physical healthcare services to integrate into its digital platforms. By the end of 2021, the company aims to be operating in more than seven countries.